Canaan Partners XI’s Tyra Biosciences TYRA Stock Holding History

Canaan Partners XI’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24M	Hold	750,000	–	–	18.82%	2
2026 Q1	$28.7M	Sell	750,000 -2,624,329	-78%	-$85M	37.76%	2
2025 Q4	$88.7M	Sell	3,374,329 -233,780	-6%	-$4.29M	64.85%	1
2025 Q3	$50.5M	Hold	3,608,109	–	–	49.07%	2
2025 Q2	$34.5M	Sell	3,608,109 -536,481	-13%	-$5.1M	20.1%	2
2025 Q1	$38.5M	Sell	4,144,590 -35,267	-0.8%	-$456K	58.09%	1
2024 Q4	$58.1M	Sell	4,179,857 -230,134	-5%	-$4.18M	75.17%	1
2024 Q3	$104M	Hold	4,409,991	–	–	87.81%	1
2024 Q2	$70.5M	Hold	4,409,991	–	–	85.38%	1
2024 Q1	$72.3M	Hold	4,409,991	–	–	79.77%	1
2023 Q4	$61.1M	Hold	4,409,991	–	–	76.34%	1
2023 Q3	$60.7M	Hold	4,409,991	–	–	53.26%	1
2023 Q2	$75.1M	Hold	4,409,991	–	–	53.19%	1
2023 Q1	$70.9M	Hold	4,409,991	–	–	50.98%	1
2022 Q4	$33.5M	Hold	4,409,991	–	–	26.32%	2
2022 Q3	$38.8M	Hold	4,409,991	–	–	15.63%	2
2022 Q2	$31.5M	Hold	4,409,991	–	–	11.23%	3
2022 Q1	$47.2M	Hold	4,409,991	–	–	19.65%	3
2021 Q4	$62M	Buy	+4,409,991	New	+$87.6M	15.98%	3

Other funds holding TYRA

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Canaan Partners XI's TYRA Position: Q2 2026 in Review

Canaan Partners XI held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 750,000 shares worth $24M. The position accounts for 18.82% of the portfolio, ranked #2.

Canaan Partners XI first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. The position peaked at $104M in Q3 2024. 16 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Canaan Partners XI held 750,000 shares of Tyra Biosciences worth $24M as of Q2 2026.
Canaan Partners XI left its Tyra Biosciences share count unchanged in Q2 2026.
Tyra Biosciences made up 18.82% of Canaan Partners XI's portfolio in Q2 2026, its #2 holding.
Canaan Partners XI first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
Canaan Partners XI's Tyra Biosciences position peaked at $104M in Q3 2024.
16 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Canaan Partners XI's 13F filing for Q2 2026, filed 20 Jul 2026.